Zoom Logo

Always Pure Organics Novel Foods Webinar 1 - Shared screen with speaker view
Harriet Brown
45:28
Can everybody hear us?
Branislava Nasteska
45:40
yes
Patrick nico
45:40
jo
Ben Hayne
45:47
yes
Harriet Brown
45:49
Thanks
Harriet Brown
46:07
Submit any questions via the chat function. Enjoy!
Mark Tallon
48:45
Have you carried out your own toxicology studies?
Harriet Brown
50:41
Thanks, your question has been notedWe'll cover additional questions at the end of the pre-submitted questions.
Mark Tallon
51:44
Do the products need characterisation using H-NMR given manufacturing can result in different stereoisomer (enantiomers). -CBD vs. +CBD have different receptor effects. Thus without know what form of CBD isomer is given have can you link your ingredients to any published literature needed for the systematic review etc?
Anna Falk
52:55
You can't differentiate enantiomers via NMR
Mark Tallon
54:02
OK thanks for the time COT disagree with you on that and the FSA may give a validation but this is not an approval but the ACNFP. Good luck with it guys.
Patrick nico
54:19
what would you advice when selling your products as White label? Is it possible to be part of that novel Food application? if yes, what does that cover?and how About Isolates in Supplements? will that work after novel Food application?
Claudia le Feuvre
57:41
Apologies if you mentioned this previously... How about broad spectrum rather than isolate?
Harriet Brown
59:17
Hi Claudia, we'll cover off your question again at the end, so not a problem.
Donna Gray
01:03:46
Do patches need FSA approval?
Harriet Brown
01:04:28
Hi Donna, thanks for your question, it has been noted and we will cover off at the end.
Marieke Hendriksen van Dongen
01:05:18
Sorry is Patrick’s question already covered?
Harriet Brown
01:06:55
HI Marieke, it may be covered in the pre-submitted questions, however we will answer all questions raised in this chat towards the end of the session.
Johan Wendner
01:07:06
Do you as a supplier of bulk material, like isolate and distillate need a novel food applications or is it only once you products target b2c?
Harriet Brown
01:10:54
Hi Johan, thanks for your question, it has been added to the list and will be covered.
Shelley Stark
01:14:09
Wouldn’t be possible for tests concerning toxicity, dosage, etc. be shared among applicants, manufacturers, if the concentration of CBD was the same, such as 10% or 20% etc.?
Ben Hayne
01:18:43
Are you submitting an application covering broad spectrum, and if so what do you believe is the chances of this being accepted?
Patrick nico
01:21:47
so that means also that Supplements can contain Isolates such as Protein powder with Isolates? cause many lawyers told us that only cosmetics can contain isolates
Shelley Stark
01:22:31
As I currently understand, one makes an application to the EU under Novel Foods and after a 9 month review, your application is placed on the Union List. Thus far the only CBD product placed on the Union List is synthetic. Is this a signal that the only CBD isolate to be allowed in the EU - for consistency - is synthetic?
Ben Hayne
01:22:44
Have you also considered the possibility of gaining organic certification on your NF products to gain a competitive# advantage?
Shelley Stark
01:25:05
Just to repeat, do you mean that an oil with CBD isolate and distillate is a food supplement and therefore not a Novel Food?
Marieke Hendriksen van Dongen
01:25:36
Elaborating to what is said now. In case you have a party like APO, which is the primary application, you than have a contract manufacturer will they use the reference code of the first application. The contract manufacturer than sells it to a vitamin brand. Will this brand then need to file for a third application?
Harriet Brown
01:33:28
Thanks for all of your questions, we have tried to cover off as many within this first hour as possible. We will review the recording and the questions and any that have not been covered will be captured for the next webinar.
Harriet Brown
01:33:56
Please do continue to submit, wither via info@alwayspureorganics.com
Claudia le Feuvre
01:34:18
Thank you so much for such an informative webinar :)
Patrick nico
01:34:43
thank you so much!
Ben Hayne
01:34:45
thank you
Donna Gray
01:34:51
Thank you - so informative!
Harriet Brown
01:34:57
We'll be posting our next dates on LinkedIn and thanks so much for joining us!